Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Based in New York City and established in 1993, TG Therapeutics, Inc. is a biopharmaceutical company that has advanced to the commercial stage.

52W Range

83rdpctl

Volume

0.43×avg

Market Cap

8.26BUSD

P/E Ratio

17.7TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

TG Therapeutics, Inc.

TGTXNASDAQ Capital Market·USD·Closed

TG Therapeutics, Inc.

TGTXNASDAQ·USD·Closed

$53.93

−3.21%

$53.93

−$1.79 (3.21%)

52W Range

83rdpctl

Volume

0.43×avg

Mkt Cap

8.26BUSD

P/E

17.7TTM

Div Yield

–ann

TGTX: TG Therapeutics, Inc. Stock Analysis | finqOS